Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2024-11-12 Share Issue/Capital Cha…
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Thông báo nhận được công văn của UBCKNN về tài liệu báo cáo phát hành cổ phiếu ESOP
Share Issue/Capital Change Classification · 93% confidence The document is a regulatory disclosure by Bepharco (DBT) to the State Securities Commission and Ho Chi Minh Stock Exchange, informing them of the receipt of the Commission’s comment on the company’s submission of documents for issuance of new shares under an employee stock option plan. It is an announcement of a capital change (new share issuance). This matches the “Share Issue/Capital Change” category (Code: SHA).
2024-11-12 Vietnamese
DBT: Giải trình BCTC Cty mẹ quý 3/2024 so với cùng kỳ năm trước
Interim / Quarterly Report Classification · 80% confidence The document is a regulatory public disclosure (“CÔNG BỐ THÔNG TIN”) of the Company’s third quarter 2024 financial statements (balance sheet, income statement, cash flow, notes) filed with the State Securities Commission and HoSE. It contains key financial data (profit after tax Q3/2024 and analysis) and represents the quarterly interim report itself, not merely a link or cover announcement. Under the definitions, it is an Interim/Quarterly Report. Q3 2024
2024-10-31 Vietnamese
DBT: Nghị quyết HĐQT thông qua việc vay vốn tại Ngân hàng TNHH MTV Shinhan Việt Nam
Capital/Financing Update Classification · 87% confidence The document is an official disclosure (“CÔNG BỐ THÔNG TIN BẤT THƯỜNG”) filed with the State Securities Commission and HOSE. It contains the Board of Directors’ resolution approving a new borrowing facility (short‐term loan) and delegates signing authority to the CEO. This is a financing activity update rather than a full financial report, earnings release, or management change. It fits the Capital/Financing Update category.
2024-10-24 Vietnamese
DBT: Đính chính Nghị quyết HĐQT số 62 ngày 19/09/2024
Share Issue/Capital Change Classification · 85% confidence The document is Bepharco’s disclosure of an extraordinary board resolution (“Nghị quyết HĐQT”) approving and correcting details of a private placement of shares: number of shares, price, investor list, use of proceeds, and foreign ownership ratio. This is not a management personnel change, earnings release, or annual/interim report, but an announcement of a new share issue/private placement—a capital change. Accordingly it best fits Share Issue/Capital Change (SHA).
2024-10-16 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua giao dịch với Ypharco Healthcare
Capital/Financing Update Classification · 80% confidence The document is a Vietnamese regulatory disclosure (“Công bố thông tin bất thường”) announcing that the Board of Directors has passed a resolution to lend 30 billion VND to Ypharco Healthcare under specified terms and authorizing the CEO to sign the loan agreement. This is not a management change, earnings release, or other category, but rather an update on the company’s financing activities (granting a loan). Therefore, it best fits the Capital/Financing Update category (CAP).
2024-10-14 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua hạn mức tín dụng tại VIB
Capital/Financing Update Classification · 85% confidence The document is a formal disclosure by Bepharco to the State Securities Commission and HoSE titled “CÔNG BỐ THÔNG TIN BẤT THƯỜNG” (announcement of unusual information) and includes the full Board resolution (Nghị quyết HĐQT) that approves a short-term credit facility (50,000 million VND limit) with VIB, details collateral, and authorizes signatories. This is not a management or board membership change (MANG), nor a dividend or share issuance notice. It clearly relates to corporate financing terms and the granting of a credit line, fitting “Capital/Financing Update” (CAP) in our taxonomy.
2024-10-09 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.